Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

IMCR Q4 2023 Earnings — Immunocore Holdings plc Revenue & Financial Results | Market Cap Arena

IMCRImmunocore Holdings plc

$2B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$71M

Gross Profit

$71M99.7% margin

Operating Income

-$17M-24.3% margin

Net Income

-$20M-28.1% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+9.1%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$597M

Total Liabilities

$228M

Stockholders' Equity

$369M

Cash & Equivalents

$443M

← FY 2023 All Quarters Q1 2024 →